labetalol hydrochloride
NDC 25021-317, labetalol hydrochloride, injection, solution, from Sagent Pharmaceuticals.
- Product NDC
- 25021-317
- Status
- Listed
- Labeler
- Sagent Pharmaceuticals
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214533
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/25021-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LABETALOL HYDROCHLORIDE5 mg/mL
Pharmacologic classes
Adrenergic beta-Antagonists [MoA]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 25021-317-20 | 25021031720 | 1 VIAL in 1 CARTON (25021-317-20) / 20 mL in 1 VIAL |
| 25021-317-40 | 25021031740 | 1 VIAL in 1 CARTON (25021-317-40) / 40 mL in 1 VIAL |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/da8af6c2-d822-4ae5-9c2d-a1d161bdefd0Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=25021-317NADAC price for package 25021031720
GET /v1/drugs/nadac/25021031720
Use it
Look up 25021-317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/25021-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 25021-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.